BRIEF published on 08/13/2025 at 07:05, 7 months 4 days ago Evotec SE Reports H1 2025 Results Highlighting Strategic Progress Financial Performance Evotec SE Strategic Growth Biologics Development H1 2025 Results
PRESS RELEASE published on 08/13/2025 at 07:00, 7 months 4 days ago Evotec SE reports H1 2025 results: Strong progress on strategy execution Evotec SE reports strong progress on strategy execution with H1 2025 results, showcasing sustainable profitable growth and key collaborations with BMS and Sandoz Evotec SE Growth Collaborations Strategy Execution H1 2025 Results
BRIEF published on 08/06/2025 at 09:57, 7 months 10 days ago Evotec SE to Release First Half-Year Results 2025 Conference Call Drug Discovery Life Sciences Evotec SE Half-year Results
PRESS RELEASE published on 08/06/2025 at 09:52, 7 months 10 days ago Evotec SE to announce first half-year results 2025 on 13 August 2025 Evotec SE to announce first half-year results for 2025 on 13 August 2025 with a conference call to discuss performance. Company focuses on drug discovery and development Conference Call Drug Discovery Evotec SE Half-year Results AI-driven Innovation
BRIEF published on 07/30/2025 at 07:21, 7 months 17 days ago Evotec and Sandoz Advance Partnership with Potential Toulouse Site Sale Strategic Partnership Evotec SE Biologics Manufacturing Sandoz AG Asset-Lighter Model
BRIEF published on 07/30/2025 at 07:19, 7 months 17 days ago Evotec SE and Sandoz AG to Potentially Sell Just – Evotec Biologics Toulouse Site Evotec SE Transaction Terms Sandoz AG Biologics Sale Toulouse Site
PRESS RELEASE published on 07/30/2025 at 07:16, 7 months 17 days ago Evotec and Sandoz evolve their strategic partnership and agree on potential sale of Just – Evotec Biologics Toulouse site Evotec and Sandoz agree on potential sale of Just – Evotec Biologics Toulouse site in strategic partnership evolution Strategic Partnership Sale Evotec Sandoz Biologics
PRESS RELEASE published on 07/30/2025 at 07:14, 7 months 17 days ago EQS-Adhoc: Evotec SE and Sandoz AG planning potential sale of Just – Evotec Biologics Toulouse site Evotec SE and Sandoz AG plan potential sale of Just - Evotec Biologics Toulouse site for $300m in cash with additional technology related consideration. Evotec to retain economic upside Evotec SE Sale Just - Evotec Biologics Toulouse Sandoz AG
BRIEF published on 07/21/2025 at 11:45, 7 months 26 days ago Evotec Adjusts Revenue Guidance for 2025 Profit Guidance Cost Optimization Evotec Revenue Guidance High-margin Technology 2028 Outlook
PRESS RELEASE published on 07/21/2025 at 11:40, 7 months 26 days ago Evotec adjusts revenue guidance and confirms profit guidance anticipating a more profitable revenue mix Evotec SE adjusts revenue guidance for fiscal year 2025, sticking to profit guidance with a focus on high-margin technology license revenues and cost optimization Evotec SE Profit Guidance Cost Optimization Revenue Guidance High-margin Technology
Published on 03/16/2026 at 22:30, 8 hours 36 minutes ago Core Silver Intersects High-Grade Copper-Molybdenum Veins up to 7.31% Cu & 1.01% Mo Confirming Large Porphyry System at Laverdiere
Published on 03/16/2026 at 22:00, 9 hours 6 minutes ago Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
Published on 03/16/2026 at 21:30, 9 hours 36 minutes ago Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Published on 03/16/2026 at 21:00, 10 hours 6 minutes ago Amdocs Brings AI-Accelerated Application Modernization to Enterprises with NVIDIA
Published on 03/17/2026 at 06:56, 10 minutes ago Basler AG: Preliminary financial results for 2025 - Basler closes 2025 at the upper end of its forecast
Published on 03/17/2026 at 06:29, 37 minutes ago Medartis builds on momentum with 16% organic sales growth and core EBITDA margin exceeding 18%
Published on 03/17/2026 at 03:40, 3 hours 26 minutes ago SANY and OCHA Sign Partnership Agreement at HNPW 2026
Published on 03/17/2026 at 02:10, 4 hours 56 minutes ago Clawchain.ai Launches on Chromia to Support the Next Generation of AI Agent Systems
Published on 03/17/2026 at 00:00, 7 hours 6 minutes ago Cango Inc. Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
Published on 03/17/2026 at 07:00, 6 minutes ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 13 hours 6 minutes ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 13 hours 8 minutes ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 13 hours 9 minutes ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
